1. Home
  2. DBVT vs DHAI Comparison

DBVT vs DHAI Comparison

Compare DBVT & DHAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DBVT
  • DHAI
  • Stock Information
  • Founded
  • DBVT 2002
  • DHAI 2007
  • Country
  • DBVT France
  • DHAI United States
  • Employees
  • DBVT N/A
  • DHAI N/A
  • Industry
  • DBVT Biotechnology: Biological Products (No Diagnostic Substances)
  • DHAI
  • Sector
  • DBVT Health Care
  • DHAI
  • Exchange
  • DBVT Nasdaq
  • DHAI NYSE
  • Market Cap
  • DBVT 67.8M
  • DHAI 55.5M
  • IPO Year
  • DBVT N/A
  • DHAI N/A
  • Fundamental
  • Price
  • DBVT $3.12
  • DHAI $1.36
  • Analyst Decision
  • DBVT Strong Buy
  • DHAI
  • Analyst Count
  • DBVT 2
  • DHAI 0
  • Target Price
  • DBVT $22.50
  • DHAI N/A
  • AVG Volume (30 Days)
  • DBVT 363.4K
  • DHAI 64.9K
  • Earning Date
  • DBVT 11-06-2024
  • DHAI 11-14-2024
  • Dividend Yield
  • DBVT N/A
  • DHAI N/A
  • EPS Growth
  • DBVT N/A
  • DHAI N/A
  • EPS
  • DBVT N/A
  • DHAI N/A
  • Revenue
  • DBVT $12,515,000.00
  • DHAI $73,490,000.00
  • Revenue This Year
  • DBVT N/A
  • DHAI N/A
  • Revenue Next Year
  • DBVT $2,860.00
  • DHAI N/A
  • P/E Ratio
  • DBVT N/A
  • DHAI N/A
  • Revenue Growth
  • DBVT 125.54
  • DHAI 16.95
  • 52 Week Low
  • DBVT $0.44
  • DHAI $0.72
  • 52 Week High
  • DBVT $4.50
  • DHAI $3.67
  • Technical
  • Relative Strength Index (RSI)
  • DBVT 60.52
  • DHAI 51.20
  • Support Level
  • DBVT $3.02
  • DHAI $1.25
  • Resistance Level
  • DBVT $3.93
  • DHAI $2.00
  • Average True Range (ATR)
  • DBVT 0.31
  • DHAI 0.24
  • MACD
  • DBVT -0.06
  • DHAI 0.00
  • Stochastic Oscillator
  • DBVT 6.76
  • DHAI 25.97

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Viaskin targets specific antigen-presenting immune cells in the skin, called Langerhans cells, that capture the antigen and migrate to the lymph node to activate the immune system without passage of the antigen into the bloodstream, minimizing systemic exposure in the body. Its main product candidate is Viaskin Peanut for the treatment of peanut-allergic patients.

About DHAI DIH HOLDINGS US INC

DIH Holding US Inc is a provider of robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions. Its products Armeo Power, Armeo Spring, Armeo Spring Pro, etc.

Share on Social Networks: